NASDAQ:MYGN

Myriad Genetics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy MYGN

*Your capital is at risk

$4.40

+0.0900 (+2.09%)

At Close: Jun 03, 2026

Myriad Genetics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 89.65. In total, the insiders bought 4.96M and sold 277.39K MYGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	89.65
● Buy	4.96M shares
● Sell	277.39K shares
58% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Mar 12, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 89.65. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 01, 2026 Buy	Common Stock J-Other	Jampa Raj Officer	Officer	0 Value: $0
Jun 01, 2026 Buy	Common Stock A-Award	Jampa Raj Chief Technology Officer	Officer	251 889 Value: $1.08M
May 14, 2026 Buy	Common Stock P-Purchase	Bisaro Paul Director	Director	7 500 Value: $27.6K
May 01, 2026 Sell	Common Stock F-InKind	Donnelly Brian J Chief Commerical Officer	Officer	55 975 Value: $268.7K
Apr 14, 2026 Sell	Common Stock F-InKind	Muzzey Dale Chief Scientific Officer	Officer	946 Value: $5K
Apr 14, 2026 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	1 069 Value: $5K
Mar 22, 2026 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	549 Value: $3K
Mar 22, 2026 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	2 055 Value: $9K
Mar 22, 2026 Sell	Common Stock F-InKind	Muzzey Dale Chief Scientific Officer	Officer	2 019 Value: $9K
Mar 15, 2026 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	2 192 Value: $10.2K
Mar 15, 2026 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	5 611 Value: $26.1K
Mar 15, 2026 Sell	Common Stock F-InKind	Muzzey Dale Chief Scientific Officer	Officer	11 949 Value: $55.7K
Mar 15, 2026 Sell	Common Stock F-InKind	Muzzey Dale Chief Scientific Officer	Officer	4 783 Value: $22.3K
Mar 15, 2026 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	9 096 Value: $42.4K
Mar 15, 2026 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	877 Value: $4K
Mar 15, 2026 Sell	Common Stock F-InKind	Haas Kevin Richard Chief Technology Officer	Officer	3 355 Value: $15.6K
Mar 15, 2026 Sell	Common Stock F-InKind	Haas Kevin Richard Chief Technology Officer	Officer	8 382 Value: $39.1K
Mar 14, 2026 Sell	Common Stock F-InKind	Raha Samraat S. President And CEO	CEO / President	10 816 Value: $50.4K
Mar 14, 2026 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	1 097 Value: $5K
Mar 14, 2026 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	5 418 Value: $25.2K
Mar 14, 2026 Sell	Common Stock F-InKind	Muzzey Dale Chief Scientific Officer	Officer	8 288 Value: $38.6K
Mar 14, 2026 Sell	Common Stock F-InKind	Solaiman Shereen Chief People Officer	Officer	5 784 Value: $27.0K
Mar 14, 2026 Sell	Common Stock F-InKind	Haas Kevin Richard Chief Technology Officer	Officer	4 161 Value: $19.4K
Mar 13, 2026 Sell	Common Stock F-InKind	Haas Kevin Richard Chief Technology Officer	Officer	6 412 Value: $29.9K
Mar 13, 2026 Sell	Common Stock F-InKind	Fox Jennifer Lynne Chief Legal Officer	Officer	5 995 Value: $27.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MYRIAD GENETICS

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing...

Read Full Profile Here